39
Participants
Start Date
April 30, 2006
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
etanercept
Given IV and subcutaneously
methylprednisolone
Given IV and orally
Columbia University Medical Center, New York
New York Medical College, Valhalla
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Medical University of South Carolina, Charleston
Children's Healthcare of Atlanta - Egleston, Atlanta
All Children's Hospital, St. Petersburg
University of Alabama at Birmingham, Birmingham
Indiana University Cancer Center, Indianapolis
Indiana University Medical Center, Indianapolis
C S Mott Children's Hospital, Ann Arbor
Midwest Children's Cancer Center, Milwaukee
Childrens Memorial Hospital, Chicago
University of Nebraska Medical Center, Omaha
Children's Hospital-Main Campus, New Orleans
University of Texas Southwestern Medical Center, Dallas
Cook Children's Medical Center, Fort Worth
Methodist Children's Hospital of South Texas, San Antonio
Children's Hospital Colorado, Aurora
Loma Linda University Medical Center, Loma Linda
Oregon Health and Science University, Portland
Seattle Children's Hospital, Seattle
Children's Oncology Group, Arcadia
Johns Hopkins University, Baltimore
Hackensack University Medical Center, Hackensack
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK